Stratos Wealth Partners, LTD. - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 102 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.89 and the average weighting 1.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$49,000
+880.0%
250,000
+2400.0%
0.00%–
Q3 2018$5,000
+150.0%
10,000
+900.0%
0.00%–
Q1 2018$2,000–1,000–0.00%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2018
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders